R66-10-5. Separation of Closed-Door Medical Cannabis Pharmacies and Medical Cannabis Processors in a Single Facility

(1) Any facility with both a closed-door pharmacy license and a license for medical cannabis processing shall ensure the physical separation of medical cannabis, which includes: (a) separating medical cannabis intended for home delivery from medical cannabis in the processing facility; (b) prohibiting the processing of medical cannabis materials in rooms designated as closed-door pharmacy areas; (c) clearly labeling medical cannabis intended for home delivery in the closed-door pharmacy; (d) storing closed-door pharmacy products and medical cannabis processor cannabis in separate secure rooms that are not accessible from the other licensed facility. (i) Final product, raw material, or processed material in inventory at the processor may not travel through the closed-door pharmacy area. (2) Upon request, the licensee shall inform the department of how it implements the separation of materials, including the facility's separation procedures for raw material, extract, and final products.